![Switches to dry powder inhalers could halve carbon footprint, study results suggest - The Pharmaceutical Journal Switches to dry powder inhalers could halve carbon footprint, study results suggest - The Pharmaceutical Journal](https://pharmaceutical-journal.com/wp-content/uploads/2022/02/dry-powder-inhaler-927x617.jpg)
Switches to dry powder inhalers could halve carbon footprint, study results suggest - The Pharmaceutical Journal
![Improved performance of dry powder inhaler capsules used to treat chronic lung disease - School of Pharmacy and Pharmaceutical Sciences - Cardiff University Improved performance of dry powder inhaler capsules used to treat chronic lung disease - School of Pharmacy and Pharmaceutical Sciences - Cardiff University](https://cardiff.imgix.net/__data/assets/image/0003/2606565/Inhalation-with-Device-resized.jpg.png?w=575&ar=16:9&q=80&auto=format)
Improved performance of dry powder inhaler capsules used to treat chronic lung disease - School of Pharmacy and Pharmaceutical Sciences - Cardiff University
![Relvar Ellipta 92micrograms/dose / 22micrograms/dose dry powder inhaler (GlaxoSmithKline UK Ltd) 30 dose - RightBreathe Relvar Ellipta 92micrograms/dose / 22micrograms/dose dry powder inhaler (GlaxoSmithKline UK Ltd) 30 dose - RightBreathe](https://www.rightbreathe.com/wp-content/uploads/2016/06/Relvar-92-22-Device-Front-Closed.jpg)
Relvar Ellipta 92micrograms/dose / 22micrograms/dose dry powder inhaler (GlaxoSmithKline UK Ltd) 30 dose - RightBreathe
![Easyhaler Salbutamol sulfate 100micrograms/dose dry powder inhaler (Orion Pharma (UK) Ltd) 200 dose - RightBreathe Easyhaler Salbutamol sulfate 100micrograms/dose dry powder inhaler (Orion Pharma (UK) Ltd) 200 dose - RightBreathe](https://www.rightbreathe.com/wp-content/uploads/2016/06/Salbutamol_sulphate_Easyhaler.jpg)
Easyhaler Salbutamol sulfate 100micrograms/dose dry powder inhaler (Orion Pharma (UK) Ltd) 200 dose - RightBreathe
![Fluticasone propionate/salmeterol (Wixela® Inhub®) dry-powder inhaler in asthma and COPD: a profile of its use in the USA | Drugs & Therapy Perspectives Fluticasone propionate/salmeterol (Wixela® Inhub®) dry-powder inhaler in asthma and COPD: a profile of its use in the USA | Drugs & Therapy Perspectives](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs40267-019-00686-w/MediaObjects/40267_2019_686_Fig1_HTML.png)
Fluticasone propionate/salmeterol (Wixela® Inhub®) dry-powder inhaler in asthma and COPD: a profile of its use in the USA | Drugs & Therapy Perspectives
![Considerations for Optimal Inhaler Device Selection in Chronic Obstructive Pulmonary Disease | Cleveland Clinic Journal of Medicine Considerations for Optimal Inhaler Device Selection in Chronic Obstructive Pulmonary Disease | Cleveland Clinic Journal of Medicine](https://www.ccjm.org/content/ccjom/85/2_suppl_1/S19/F1.large.jpg)